Previous Article | Next Article 
Antimicrob Agents Chemother. 1993 December; 37(12): 2633-2637
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.
M Maurin and
D Raoult
Unite des Rickettsies, Faculte de Medecine, Marseille, France.
ABSTRACT
The in vitro bacteriostatic activity of clarithromycin, a new macrolide derivative, against Rickettsia rickettsii, Rickettsia conorii, and "Rickettsia israeli" was determined by the plaque assay and the dye uptake assay. Both bacteriostatic and bactericidal activities of clarithromycin against the Nine Mile, Q212, Priscilla, and ME9 strains of Coxiella burnetti were evaluated by using three cell culture systems. Clarithromycin showed improved antibacterial activity compared with that of erythromycin. A bacteriostatic activity was obtained at concentrations below the reported maximum concentration of clarithromycin in human serum (about 4 micrograms/ml) for all tested rickettsiae. MICs ranged from 1 to 2 micrograms/ml for the three Rickettsia species and from 1 to 4 micrograms/ml for the C. burnetti strains. No bactericidal activity against C. burnetti was obtained when clarithromycin was used at 4 micrograms/ml.
Antimicrob Agents Chemother. 1993 December; 37(12): 2633-2637
This article has been cited by other articles:
-
CONE, L. A., CURRY, N., SHAVER, P., BROOKS, D., DEFORGE, J., POTTS, B. E.
(2006). Q Fever in the southern california desert: epidemiology, clinical presentation and treatment.. Am J Trop Med Hyg
75: 29-32
[Abstract]
[Full Text]
-
MOROVIC, M.
(2005). Q FEVER PNEUMONIA: ARE CLARITHROMYCIN AND MOXIFLOXACIN ALTERNATIVE TREATMENTS ONLY?. Am J Trop Med Hyg
73: 947-948
[Abstract]
[Full Text]
-
Gikas, A., Kofteridis, D. P., Manios, A., Pediaditis, J., Tselentis, Y.
(2001). Newer Macrolides as Empiric Treatment for Acute Q Fever Infection. Antimicrob. Agents Chemother.
45: 3644-3646
[Abstract]
[Full Text]
-
Gikas, A., Spyridaki, I., Scoulica, E., Psaroulaki, A., Tselentis, Y.
(2001). In Vitro Susceptibility of Coxiella burnetii to Linezolid in Comparison with Its Susceptibilities to Quinolones, Doxycycline, and Clarithromycin. Antimicrob. Agents Chemother.
45: 3276-3278
[Abstract]
[Full Text]
-
Brouqui, P., Raoult, D.
(2001). Endocarditis Due to Rare and Fastidious Bacteria. Clin. Microbiol. Rev.
14: 177-207
[Abstract]
[Full Text]
-
Rolain, J.-M., Maurin, M., Bryskier, A., Raoult, D.
(2000). In Vitro Activities of Telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother.
44: 1391-1393
[Abstract]
[Full Text]
-
Ives, T. J., Marston, E. L., Regnery, R. L., Butts, J. D., Majerus, T. C.
(2000). In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. J Antimicrob Chemother
45: 305-310
[Abstract]
[Full Text]
-
Maurin, M., Raoult, D.
(1999). Q Fever. Clin. Microbiol. Rev.
12: 518-553
[Abstract]
[Full Text]
-
Gikas, A., Spyridaki, I., Psaroulaki, A., Kofterithis, D., Tselentis, Y.
(1998). In Vitro Susceptibility of Coxiella burnetii to Trovafloxacin in Comparison with Susceptibilities to Pefloxacin, Ciprofloxacin, Ofloxacin, Doxycycline, and Clarithromycin. Antimicrob. Agents Chemother.
42: 2747-2748
[Abstract]
[Full Text]
-
Rolain, J. M., Maurin, M., Vestris, G., Raoult, D.
(1998). In Vitro Susceptibilities of 27 Rickettsiae to 13 Antimicrobials. Antimicrob. Agents Chemother.
42: 1537-1541
[Abstract]
[Full Text]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.